Austar Lifesciences Limited (AUSTAR) reported no changes in either its authorised or issued share capital for the month ended 30 April 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing on 5 May 2026.
Authorised Capital • Remained unchanged at 10.00 billion ordinary shares with a par value of HKD0.01 each, equivalent to HKD100.00 million in authorised share capital.
Issued Share Position • Total issued shares (excluding treasury shares) stood at 512.58 million, identical to the balance at the end of March 2026. • The company held no treasury shares during the period, keeping the total number of issued shares at 512.58 million.
Capital Movements • The filing records no activity in share options, warrants, convertible securities, or other equity-linked instruments. • There were no share repurchases, cancellations, or placements in April.
Public Float • AUSTAR confirmed compliance with the Main Board’s minimum public float requirement of 25 percent of issued shares.
Administrative Details • The submission was signed by Company Secretary Mak Yuk Kiu and classified as a “New Submission” under Chapter 19B of the Listing Rules.
With the share base and capital structure unchanged, AUSTAR enters May 2026 maintaining stability in its equity profile while meeting all listing obligations.
Comments